biocon-ltd-hebbagodi-bangalore-ukif4_web

Mylan and Biocon Neulasta biosimilar knocked back by FDA

October 11, 2017
Research and Development, Sales and Marketing Amgen, Biocon, Mylan, Neulasta, biotech, drugs, pharma, pharmaceutical

Mylan and Biocon’s biosimilar version of Amgen’s blockbuster, Neulasta (pegfilgrastim), will have to wait a bit longer before getting the …

allergan

Allergan settles gender discrimination case for $4m

October 11, 2017
Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

It could have been much worse for Allergan, after it agreed to pay $4 million to resolve a lawsuit alleging …

david-crossman300_web

NHS Scotland appoints new Chief Scientist

October 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Scotland, biotech, drugs, pharma, pharmaceutical

NHS Scotland has revealed the appointment of Professor David Crossman as its new Chief Scientist, after advertising externally to fill …

fire-166421_960_720

Use of antacids found to promote liver disease

October 10, 2017
Manufacturing and Production, Research and Development biotech, drugs, liver disease, pharma, pharmaceutical

A study emerging from the University of California, San Diego, has revealed a correlation between the use of common acid …

mental-health-2019924_960_720

Scottish government reveals extra funding for mental health

October 10, 2017
Manufacturing and Production, Medical Communications Scotland, biotech, drugs, mental health, pharma, pharmaceutical

The Scottish government, on Mental Health Day, has revealed that it will boost spending on mental health services by £500,000. …

california-2798001_960_720

California signs into law transparency over drug pricing

October 10, 2017
Manufacturing and Production, Sales and Marketing Drug pricing, biotech, california, drugs, pharma, pharmaceutical

In a move that is guaranteed to result in further lawsuits and acrimony, California has signed into law a requirement …

GSK ranked at bottom of ‘good governance’ report

October 10, 2017
Manufacturing and Production, Medical Communications Diageo, GSK, biotech, drugs, pharma, pharmaceutical

A new report emerging from the Institute of Directors placed UK pharma giant, GSK, in last place out of 103 …

jj

J&J exits insulin pump business, rival looks to scoop patients

October 10, 2017
Manufacturing and Production Johnson & Johnson, biotech, diabetes, drugs, pharma, pharmaceutical

Johnson & Johnson’s Animas Corporation will cease business and close operations after the pharma giant could not find a buyer …

shutterstock_360472550

Harnessing the power of the immune system

October 9, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, immunotherapy, pharma, pharmaceuticals

Dr Áine McCarthy, Senior Science Information Officer at Cancer Research UK, discusses the latest efforts to further understand the immunotherapies …

roche_close

Roche’s 99% accurate Zika test receives FDA approval

October 9, 2017
Sales and Marketing Roche, Zika, biotech, drugs, pharma, pharmaceutical

Roche has revealed that the FDA has given approval to its cobas Zika test to determine whether a blood sample …

astrazeneca-sign

AstraZeneca’s Tagrisso secures Breakthrough Therapy Designation in first-line NSCLC

October 9, 2017
Sales and Marketing AstraZeneca, Cancer, NSCLC, immunotherapy, lung cancer

AstraZeneca has announced that its targeted therapy, Tagrisso (osimertinib), has been awarded Breakthrough Therapy Designation by the FDA for the …

contraceptive-pills-849413_960_720

Trump sweeps away birth control coverage

October 9, 2017
Medical Communications, Sales and Marketing President trump, Trump, biotech, birth control, drugs, pharma, pharmaceutical

Part of Obama’s Affordable Care Act included the provision that employer-provided health insurance must cover birth control, President Trump has …

800px-flag_of_the_peoples_republic_of_china

China to accelerate drug approvals with overseas trial data

October 9, 2017
Research and Development, Sales and Marketing China, drug approvals, pharma, pharmaceuticals

In a bid to speed up access to medicines for patients, China has revealed it intends to incorporate data from …

sleeping_man

Battery implant approved to treat sleep apnea

October 9, 2017
Sales and Marketing FDA, biotech, drugs, pharma, pharmaceutical

The FDA has announced the approval of a new form of treatment for central sleep apnea, in the form of …

Sanofi promotes global head of diabetes to expand role

October 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, biotech, diabetes, drugs, pharma, pharmaceutical

Sanofi has promoted Stefan Oelrich to the position of Executive Vice President of Diabetes and Cardiovascular (DCV), giving him a …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The week has flown by and was packed with a number of shocking stories. With the ongoing uncertainty regarding Brexit, …

androgel

AbbVie hit with $140m fine over fraudulent marketing of Androgel

October 6, 2017
Medical Communications, Sales and Marketing AbbVie, androgel, biotech, drugs, pharma, pharmaceutical

AbbVie has been stung with a $140 million damages award to a man that suffered a heart attack after using …

At least 40% of Afghanistan’s medicine imported illegally, union claims

October 6, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing afghanistan, pharma, pharmaceuticals

New damning allegations have arisen concerning Afghanistan’s pharmaceutical industry, as the Medicine Importers Union claims that at least 40% of …

bayer_cross_2

Bayer forced to halt huge study into key drug

October 6, 2017
Medical Communications, Research and Development Bayer, Janssen, Xarelto, biotech, drugs, pharma, pharmaceutical

Bayer, and development partner Janssen, have been forced to stop a Phase 3 trial looking at expanding the indication of …

aspen

South Africa’s over-charging case against Aspen dissolves, remains against big names

October 6, 2017
Medical Communications, Sales and Marketing Genentech, Pfizer, Roche, aspen, biotech, drugs, pharma, pharmaceutical

South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …

The Gateway to Local Adoption Series

Latest content